Advisor Net Financial, Inc Bio N Tech Se Transaction History

Advisor Net Financial, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$80.36 - $102.87 $241 - $308	-3 Reduced 1.48%	200 $16,000
Q1 2024 Apr 12, 2024	BUY	$88.96 - $112.35 $18,058 - $22,807	203 New	203 $18,000
Q3 2022 Oct 04, 2022	SELL	$127.65 - $183.11 $893 - $1,281	-7 Reduced 58.33%	5 $1,000
Q4 2021 Jan 19, 2022	BUY	$216.64 - $362.52 $1,516 - $2,537	7 Added 140.0%	12 $3,000
Q3 2021 Oct 15, 2021	BUY	$205.93 - $447.23 $1,029 - $2,236	5 New	5 $1,000

365

39.7M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.